Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05796531 · ClinicalTrials.gov registry record · NA

Therapeutic Evaluative Conditioning to Reduce Adolescents' Self-injurious Thoughts and Behaviors During and After Psychiatric Inpatient Hospitalization

A NA study of Suicidal Ideation and Self Injurious Behavior, sponsored by Franciscan Hospital For Children.

Recruiting
Registry status
NA
Development phase
155
Enrollment target
1
Study location

NCT05796531: Recruiting NA study of Suicidal Ideation and Self Injurious Behavior, sponsored by Franciscan Hospital For Children.

NCT05796531 is a NA study of Suicidal Ideation and Self Injurious Behavior that is actively recruiting participants, run by Franciscan Hospital For Children. The registered enrollment target is 155 participants, below the 266-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05796531, a NA study of Suicidal Ideation and Self Injurious Behavior, is actively recruiting participants, sponsored by Franciscan Hospital For Children.

RECRUITING
Registry status
NA
Development phase
155 participants
Enrollment target
1
Study location

Study Summary

Suicide is the 2nd leading cause of death among adolescents, with the highest risk period for suicide being the month following psychiatric inpatient hospitalization. The investigators propose testing a brief, scalable intervention using evaluative conditioning aimed at reducing suicidal thoughts and behaviors among adolescents during and after inpatient hospitalization. Scalable interventions, such as the one proposed that reduce suicide risk during this markedly high-risk period, could result in large-scale decreases in suicide death.

Primary Outcome

The investigators will assess the presence and frequency of non-suicidal self-injury, suicidal thoughts, suicide plans, suicide attempts and other suicidal behaviors, such as aborted suicide attempts. The investigators will also assess the severity of suicidal thoughts as well.

Interventions

  • BEHAVIORAL Therapeutic Evaluative Conditioning
  • BEHAVIORAL Neutral comparison condition

Study Locations (1)

Massachusetts

  • Franciscan Hospital For Children, Inc. - Brighton

Trial Details

FieldValue
Enrollment Target 155 participants
Start Date 2023-03-31
Est. Completion 2026-12-31
Phase NA
Franciscan Hospital For Children

1 total trials

What NCT05796531 shows while recruiting

NCT05796531 is an interventional study that assigns participants to a tested intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap, below the 266-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (42% lower).

The record links to 3 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 2 interventions - of which Therapeutic Evaluative Conditioning is the first listed.

NCT05796531 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05796531 about?

NCT05796531 is a clinical study titled "Therapeutic Evaluative Conditioning to Reduce Adolescents' Self-injurious Thoughts and Behaviors During and After Psychiatric Inpatient Hospitalization". Suicide is the 2nd leading cause of death among adolescents, with the highest risk period for suicide being the month following psychiatric inpatient hospitalization. The investigators propose testing a brief, scalable intervention using evaluative conditioning aimed at reducing suicidal thoughts an...

What is the current status of trial NCT05796531?

This trial is currently recruiting. It is a NA study. The enrollment target is 155 participants. The study started on 2023-03-31. Estimated completion is 2026-12-31.

What conditions does trial NCT05796531 study?

This clinical trial studies the following conditions: Suicidal Ideation, Self Injurious Behavior, Suicide Attempts.

What interventions are being tested in trial NCT05796531?

The interventions under investigation include: Therapeutic Evaluative Conditioning (BEHAVIORAL), Neutral comparison condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT05796531?

This trial is sponsored by Franciscan Hospital For Children, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05796531 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicidal Ideation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05796531's enrollment target sits among peer trials

155 35th of 84 higher than 50 of 84 other Suicidal Ideation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03223610 · 155 participants · Phase 1

    Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

  • NCT05072483 · 155 participants

    Natural History Study of CADASIL

  • NCT05086497 · 155 participants · NA

    WBSI Guided Personalized Delivery of TTFields

  • NCT05412069 · 155 participants · NA

    Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05796531, the US trial registry maintained by the National Library of Medicine. NCT05796531 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.